Toxoplasmosis in pregnancy and its transmission to the fetus.
作者信息
Desmonts G, Couvreur J
出版信息
Bull N Y Acad Med. 1974 Feb;50(2):146-59.
Abstract
摘要
相似文献
1
Toxoplasmosis in pregnancy and its transmission to the fetus.孕期弓形虫病及其向胎儿的传播。
Bull N Y Acad Med. 1974 Feb;50(2):146-59.
2
Congenital toxoplasmosis. A prospective study of 378 pregnancies.先天性弓形虫病。对378例妊娠的前瞻性研究。
N Engl J Med. 1974 May 16;290(20):1110-6. doi: 10.1056/NEJM197405162902003.
3
Toxoplasmosis.
Med J Aust. 1970 Aug 29;2(9):418-21.
4
5
New perspectives in the chemoprophylaxis of toxoplasmosis.
J Chemother. 1989 Feb;1(1):46-51. doi: 10.1080/1120009x.1989.11738863.
6
[Treatment of toxoplasmosis acquired during pregnancy with spiramycin].
Zentralbl Gynakol. 1983;105(17):1104-7.
7
Toxoplasmosis.弓形虫病
J Natl Med Assoc. 1973 Sep;65(5):399-401 passim.
8
[Epidemiology, clinical aspects and therapy of toxoplasmosis].[弓形虫病的流行病学、临床特征及治疗]
Med Klin. 1970 Feb 13;65(7):283-8.
9
[Congenital toxoplasmosis. Evaluation of the benefit of prenatal therapy].[先天性弓形虫病。产前治疗益处的评估]
J Gynecol Obstet Biol Reprod (Paris). 1976 Mar;5(2):265-9.
10
[Epidemiology of toxoplasmosis].[弓形虫病的流行病学]
Rev Med Suisse Romande. 1974 Apr;94(4):261-9.
引用本文的文献
1
A review of natural products as a source of next-generation drugs against apicomplexan parasites.天然产物作为抗顶复门寄生虫的下一代药物来源的综述。
NPJ Antimicrob Resist. 2025 Jun 6;3(1):51. doi: 10.1038/s44259-025-00119-x.
2
Preexisting vaccine-primed heterosubtypic T cell immunity protects the maternal-fetal unit from adverse influenza outcomes in mice.预先存在的疫苗引发的异源亚型T细胞免疫可保护母胎单位免受小鼠流感不良后果的影响。
J Clin Invest. 2025 Jan 2;135(1):e179230. doi: 10.1172/JCI179230.
3
Modeling the human placental barrier to understand ´s vertical transmission.建立人类胎盘屏障模型以了解垂直传播。
Front Cell Infect Microbiol. 2023 Mar 9;13:1130901. doi: 10.3389/fcimb.2023.1130901. eCollection 2023.
4
Anti- IgM Long Persistence: What Are the Underlying Mechanisms?抗IgM的长期持续存在：潜在机制是什么？
Microorganisms. 2022 Aug 17;10(8):1659. doi: 10.3390/microorganisms10081659.
5
Evaluation of Essential Oil and Its Active Ingredients as Potential Drugs for the Treatment of Toxoplasmosis.评价精油及其活性成分作为治疗弓形虫病的潜在药物。
Front Cell Infect Microbiol. 2021 Nov 22;11:793089. doi: 10.3389/fcimb.2021.793089. eCollection 2021.
6
Congenital toxoplasmosis in humans: an update of worldwide rate of congenital infections.先天性弓形虫病在人类中的情况：全球先天性感染率的最新更新。
Parasitology. 2021 Oct;148(12):1406-1416. doi: 10.1017/S0031182021001013. Epub 2021 Jun 18.
7
Anti-parasitic Activity of Essential Oil Against .香精油对……的抗寄生虫活性
Front Cell Dev Biol. 2021 Feb 18;9:616340. doi: 10.3389/fcell.2021.616340. eCollection 2021.
8
Prevention and mitigation of congenital toxoplasmosis. Economic costs and benefits in diverse settings.先天性弓形虫病的预防与缓解。不同环境下的经济成本与效益。
Food Waterborne Parasitol. 2019 Jun 1;16:e00058. doi: 10.1016/j.fawpar.2019.e00058. eCollection 2019 Sep.
9
Treatment of toxoplasmosis: Current options and future perspectives.弓形虫病的治疗：当前选择与未来展望
Food Waterborne Parasitol. 2019 Apr 1;15:e00036. doi: 10.1016/j.fawpar.2019.e00036. eCollection 2019 Jun.
10
Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice.弓形虫病的治疗：历史视角、动物模型和当前临床实践。
Clin Microbiol Rev. 2018 Sep 12;31(4). doi: 10.1128/CMR.00057-17. Print 2018 Oct.
本文引用的文献
1
[Spiramycin therapy of experimental toxoplasmosis in mice].[小鼠实验性弓形虫病的螺旋霉素治疗]
Presse Med (1893). 1958 May 28;66(42):957-8.
2
[Theoretical bases of the prevention by spiramycin of congenital toxoplasmosis in pregnant women].[螺旋霉素预防孕妇先天性弓形虫病的理论基础]
Presse Med (1893). 1968 Dec 7;76(48):2266.
3
[Cultivation tests of toxoplasma gondii from placentas and abortion material and serological examination of women with toxoplasma antibodies].
Z Geburtshilfe Perinatol. 1972 Aug;176(4):324-30.
4
Clinical Toxoplasmosis--50 years.
Trans R Soc Trop Med Hyg. 1972;66(4):549-71. doi: 10.1016/0035-9203(72)90300-8.
5
Toxoplasmosis in pregnancy.
J Obstet Gynaecol Br Commonw. 1972 Dec;79(12):1115-8. doi: 10.1111/j.1471-0528.1972.tb11897.x.
Zotero 插件